UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 106

Sortiert nach

C/EBPB-dependent adaptation to palmitic acid promotes tumor formation in hormone receptor negative breast cancer

Nature communications, 2022-01, Vol.13 (1), p.69-69, Article 69

2022

Volltextzugriff (PDF)

Genome-Wide DNA Methylation Analysis in Melanoma Reveals the Importance of CpG Methylation in MITF Regulation

Journal of investigative dermatology, 2015-07, Vol.135 (7), p.1820-1828

2015

Volltextzugriff (PDF)

Adjuvant Aromatase Inhibitors for Early Breast Cancer After Chemotherapy-Induced Amenorrhoea: Caution and Suggested Guidelines

Journal of clinical oncology, 2006-06, Vol.24 (16), p.2444-2447

2006

Volltextzugriff (PDF)

Repeated Observation of Breast Tumor Subtypes in Independent Gene Expression Data Sets

Proceedings of the National Academy of Sciences - PNAS, 2003-07, Vol.100 (14), p.8418-8423

2003

Volltextzugriff (PDF)

Predicting long-term survival and treatment response in breast cancer patients receiving neoadjuvant chemotherapy by MR metabolic profiling

NMR in biomedicine, 2012-02, Vol.25 (2), p.369-378

2012

Volltextzugriff (PDF)

Poor-prognosis estrogen receptor- positive disease: present and future clinical solutions

Therapeutic Advances in Medical Oncology, 2012-05, Vol.4 (3), p.127-137

Lønning, Per E.

2012

Volltextzugriff (PDF)

Effects of the MDM2 promoter SNP285 and SNP309 on Sp1 transcription factor binding and cancer risk

Transcription, 2011-09, Vol.2 (5), p.207-210

2011

Volltextzugriff (PDF)

Comment on "Towards a personalized approach to aromatase inhibitor therapy: a digital microfluidic platform for rapid analysis of estradiol in core-needle-biopsies" by S. Abdulwahab, A. H. C. Ng, M. D. Chamberlain, H. Ahmado, L.-A. Behan, H. Gomaa, R. F. Casper and A. R. Wheeler, Lab Chip, 2017, 17, 1594

Lab on a chip, 2017-09, Vol.17 (18), p.3186-3187

Lønning, Per E

2017

Volltextzugriff (PDF)

Impact of aromatase inhibitors on bone health in breast cancer patients

Journal of steroid biochemistry and molecular biology, 2010-02, Vol.118 (4), p.294-299

2010

Volltextzugriff (PDF)

Functional characterisation of p53 mutants identified in breast cancers with suboptimal responses to anthracyclines or mitomycin

Biochimica et biophysica acta, 2013-03, Vol.1830 (3), p.2790-2797

2013

Volltextzugriff (PDF)

The Functional Roles of the MDM2 Splice Variants P2-MDM2-10 and MDM2-∆5 in Breast Cancer Cells

Translational oncology, 2017-10, Vol.10 (5), p.806-817

2017

Volltextzugriff (PDF)

Impact of the APOBEC3A/B deletion polymorphism on risk of ovarian cancer

Scientific reports, 2021-12, Vol.11 (1), p.23463-23463, Article 23463

2021

Volltextzugriff (PDF)

Recent data on intratumor estrogens in breast cancer

Steroids, 2011-07, Vol.76 (8), p.786-791

2011

Volltextzugriff (PDF)

Differential inhibition of ex-vivo tumor kinase activity by vemurafenib in BRAF(V600E) and BRAF wild-type metastatic malignant melanoma

PloS one, 2013-08, Vol.8 (8), p.e72692-e72692

2013

Volltextzugriff (PDF)

Alterations in the p53 Pathway and p16INK4a Expression Predict Overall Survival in Metastatic Melanoma Patients Treated with Dacarbazine

Journal of investigative dermatology, 2010-10, Vol.130 (10), p.2514-2516

2010

Volltextzugriff (PDF)

Aromatase inhibitors: Assessment of biochemical efficacy measured by total body aromatase inhibition and tissue estrogen suppression

Journal of steroid biochemistry and molecular biology, 2008-02, Vol.108 (3), p.196-202

2008

Volltextzugriff (PDF)

Prenatal BRCA1 epimutations contribute significantly to triple-negative breast cancer development

Genome medicine, 2023-12, Vol.15 (1), p.104-15, Article 104

2023

Volltextzugriff (PDF)

Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy

Genome medicine, 2022-08, Vol.14 (1), p.1-86, Article 86

2022

Volltextzugriff (PDF)

Polymorphisms in the TP53-MDM2-MDM4-axis in patients with rheumatoid arthritis

Gene, 2021-08, Vol.793, p.145747-145747, Article 145747

2021

Volltextzugriff (PDF)

A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer

The New England journal of medicine, 2004-03, Vol.350 (11), p.1081-1092

2004

Volltextzugriff (PDF)

Constitutional Mosaic Epimutations - a hidden cause of cancer?

Cell Stress, 2019-03, Vol.3 (4), p.118-135

2019

Volltextzugriff (PDF)

Impact of MDM2 promoter SNP55 (rs2870820) on risk of endometrial and ovarian cancer

Biomarkers, 2021-05, Vol.26 (4), p.302-308

2021

Volltextzugriff (PDF)

Molecular portraits of human breast tumours

Nature (London), 2000-08, Vol.406 (6797), p.747-752

2000

Volltextzugriff (PDF)

Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancer

NMR in biomedicine, 2012-09, Vol.25 (9), p.1033-1042

2012

Volltextzugriff (PDF)

Aromatase inhibitors—Socioeconomical issues

Journal of steroid biochemistry and molecular biology, 2007-08, Vol.106 (1), p.55-61

2007

Volltextzugriff (PDF)

1 – 25 von 106

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(104)
Mit Volltextzugriff
(91)

Publikationsform

Artikel
(105)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(78)
Science & Technology
(73)
Life Sciences & Biomedicine
(63)
Female
(50)
Biological And Medical Sciences
(39)
Medical Sciences
(35)
Breast Neoplasms - Drug Therapy
(32)
Breast Cancer
(29)
Tumors
(25)
Middle Aged
(24)
Biochemistry & Molecular Biology
(22)
Endocrinology & Metabolism
(21)
Aromatase Inhibitors
(18)
Aged
(17)
Pharmacology. Drug Treatments
(16)
Chemotherapy
(15)
Breast Neoplasms - Metabolism
(14)
Fundamental And Applied Biological Sciences. Psychology
(14)
Adult
(13)
Gynecology. Andrology. Obstetrics
(13)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

C/EBPB-dependent adaptation to palmitic acid promotes tumor formation in hormone receptor negative breast cancer

Genome-Wide DNA Methylation Analysis in Melanoma Reveals the Importance of CpG Methylation in MITF Regulation

Adjuvant Aromatase Inhibitors for Early Breast Cancer After Chemotherapy-Induced Amenorrhoea: Caution and Suggested Guidelines

Repeated Observation of Breast Tumor Subtypes in Independent Gene Expression Data Sets

Predicting long-term survival and treatment response in breast cancer patients receiving neoadjuvant chemotherapy by MR metabolic profiling

Poor-prognosis estrogen receptor- positive disease: present and future clinical solutions

Effects of the MDM2 promoter SNP285 and SNP309 on Sp1 transcription factor binding and cancer risk

Impact of aromatase inhibitors on bone health in breast cancer patients

Functional characterisation of p53 mutants identified in breast cancers with suboptimal responses to anthracyclines or mitomycin

The Functional Roles of the MDM2 Splice Variants P2-MDM2-10 and MDM2-∆5 in Breast Cancer Cells

Impact of the APOBEC3A/B deletion polymorphism on risk of ovarian cancer

Recent data on intratumor estrogens in breast cancer

Differential inhibition of ex-vivo tumor kinase activity by vemurafenib in BRAF(V600E) and BRAF wild-type metastatic malignant melanoma

Alterations in the p53 Pathway and p16INK4a Expression Predict Overall Survival in Metastatic Melanoma Patients Treated with Dacarbazine

Aromatase inhibitors: Assessment of biochemical efficacy measured by total body aromatase inhibition and tissue estrogen suppression

Prenatal BRCA1 epimutations contribute significantly to triple-negative breast cancer development

Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy

Polymorphisms in the TP53-MDM2-MDM4-axis in patients with rheumatoid arthritis

A Randomized Trial of Exemestane after Two to Three Years of Tamoxifen Therapy in Postmenopausal Women with Primary Breast Cancer

Constitutional Mosaic Epimutations - a hidden cause of cancer?

Impact of MDM2 promoter SNP55 (rs2870820) on risk of endometrial and ovarian cancer

Molecular portraits of human breast tumours

Glycerophosphodiester phosphodiesterase domain containing 5 (GDPD5) expression correlates with malignant choline phospholipid metabolite profiles in human breast cancer

Aromatase inhibitors—Socioeconomical issues

Aktive Filter

Suchergebnisse filtern